FDA to Host Public Workshop on Naloxone Access

The U.S. Food and Drug Administration (FDA) will host a virtual public workshop on Tuesday, March 29 from 9:30 am to 12:00 pm to discuss critical questions around access to naloxone. The workshop is a collaboration with the Reagan-Udall Foundation for the FDA.

The workshop will provide an in-depth discussion to review the current landscape of naloxone availability, address perceived barriers to naloxone access, and address questions posed by various groups on the subject. In addition, various stakeholders, including harm-reduction specialists, physicians, pharmacists, and regulators, will also share their experiences in addressing the availability of naloxone for opioid overdose.

Additional information, including registration, is available here.